cs060380
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 30, 2024 (NCT06573528)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
THRB agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07198386 | Phase 2 | Sep 30, 2025 | Hangzhou Normal University |
| NCT06573528 | Phase 1 | Aug 30, 2024 | Jiao Tong University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hangzhou Normal University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1